STAT4: Genetics, mechanisms, and implications for autoimmunity

Vyse TJ, Todd JA: Genetic analysis of autoimmune disease. Cell 1996, 85:311–318.

Goronzy J, Weyand CM, Fathman CG: Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritis. J Clin Invest 1986, 77:1042–1049.

Harley JB, Kelly JA, Kaufman KM: Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 2006, 28:119–130.

Jawaheer D, Seldin MF, Amos CI, et al.: A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001, 68:927–936.

Bottini N, Musumeci L, Alonso A, et al.: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337–338.

Begovich AB, Carlton VE, Honigberg LA, et al.: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75:330–337.

Vang T, Miletic AV, Bottini N, Mustelin T: Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007, 40:453–461.

Kyogoku C, Langefeld CD, Ortmann WA, et al.: Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004, 75:504–507.

Plenge RM, Seielstad M, Padyukov L, et al.: TRAF1-C5 as a risk locus for rheumatoid arthritis—a genomewide study. N Engl J Med 2007, 357:1199–1209.

Plenge RM, Cotsapas C, Davies L, et al.: Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007, 39:1477–1482.

Thomson W, Barton A, Ke X, et al.: Rheumatoid arthritis association at 6q23. Nat Genet 2007, 39:1431–1433.

Harley JB, Alarcon-Riquelme ME, Criswell LA, et al.: Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40:204–210.

Hom G, Graham RR, Modrek B, et al.: Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008, 358:900–909.

Kozyrev SV, Abelson AK, Wojcik J, et al.: Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008, 40:211–216.

van Heel DA, Franke L, Hunt KA, et al.: A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007, 39:827–829.

Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661–678.

Zhernakova A, Alizadeh BZ, Bevova M, et al.: Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet 2007, 81:1284–1288.

Amos CI, Chen WV, Lee A, et al.: High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. Genes Immun 2006, 7:277–286.

Remmers EF, Plenge RM, Lee AT, et al.: STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977–986.

Barton A, Thomson W, Ke X, et al.: Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet 2008 Apr 22 (Epub ahead of print).

Kurreeman FA, Padyukov L, Marques RB, et al.: A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007, 4:e278.

Kallberg H, Padyukov L, Plenge RM, et al.: Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007, 80:867–875.

Lee HS, Remmers EF, Le JM, et al.: Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med 2007, 13:455–460.

Palomino-Morales RJ, Rojas-Villarraga A, Gonzalez CI, et al.: STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun 2008, 9:379–382.

Cantor RM, Yuan J, Napier S, et al.: Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12–13, and 17q21–23 and novel evidence at 3p24, 10q23–24, 13q32, and 18q22–23. Arthritis Rheum 2004, 50:3203–3210.

Taylor KE, Remmers E, Lee A, et al.: Specificity of the STAT4 genetics association with severe disease manifestations of systemic lupus erythematosus. PLoS Genet 2008, 4:e1000084.

Korman BD, Alba MI, Le JM, et al.: Variant form of STAT4 is associated with primary Sjogren’s syndrome. Genes Immun 2008, 9:267–270.

Li Y, Wu B, Xiong H, et al.: Polymorphisms of STAT-6, STAT-4 and IFN-gamma genes and the risk of asthma in Chinese population. Respir Med 2007, 101:1977–1981.

Pykalainen M, Kinos R, Valkonen S, et al.: Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J Allergy Clin Immunol 2005, 115:80–87.

Park BL, Cheong HS, Kim LH, et al.: Association analysis of signal transducer and activator of transcription 4 (STAT4) polymorphisms with asthma. J Hum Genet 2005, 50:133–138.

Horvath CM: STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 2000, 25:496–502.

Watford WT, Hissong BD, Bream JH, et al.: Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139–156.

Grusby MJ: Stat4-and Stat6-deficient mice as models for manipulating T helper cell responses. Biochem Soc Trans 1997, 25:359–360.

Jacob CO, Zang S, Li L, et al.: Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J Immunol 2003, 171:1564–1571.

Singh RR, Saxena V, Zang S, et al.: Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 2003, 170:4818–4825.

Finnegan A, Grusby MJ, Kaplan CD, et al.: IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol 2002, 169:3345–3352.

Behera AK, Kumar M, Lockey RF, Mohapatra SS: Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum Gene Ther 2002, 13:1697–1709.

Hildner KM, Schirmacher P, Atreya I, et al.: Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis. J Immunol 2007, 178:3427–3436.

Nandakumar KS, Holmdahl R: Arthritis induced with cartilage-specific antibodies is IL-4-dependent. Eur J Immunol 2006, 36:1608–1618.

Klinman DM, Gursel I, Klaschik S, et al.: Therapeutic potential of oligonucleotides expressing immunosuppressive TTAGGG motifs. Ann N Y Acad Sci 2005, 1058:87–95.

Shirota H, Gursel M, Klinman DM: Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma-and IL-12-mediated signaling. J Immunol 2004, 173:5002–5007.

Thierfelder WE, van Deursen JM, Yamamoto K, et al.: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996, 382:171–174.

Fukao T, Frucht DM, Yap G, et al.: Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J Immunol 2001, 166:4446–4455.